ALLISON GUTIERREZ: Open Payments
NPI 1871936245 · PASADENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$247 in 9 payments from 5 companies in 2025. Trend: 2023 $444 · 2024 $606 · 2025 $247
Food & beverage: $247
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $101 |
| Vanda Pharmaceuticals Inc. | 2 | $67 |
| PFIZER INC. | 2 | $40 |
| Lilly USA, LLC | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: INGREZZA, HETLIOZ, PAXLOVID, KISUNLA, REXULTI.
Industry payments across CA — which companies pay providers there.
